From September 2014 to July 2021, a total of 75 CP-B patients with locally advanced HCC with a base-line CP score of B7 (59 patients), B8 (13 patients) and B9 (3 patients) met the criteria and were enrolled (Fig. 1). The gene discussed is CP; the disease is hepatocellular carcinoma.